Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc. (SPTX) Insider Trading
Directors, officers and holders of more than 10% of SPTX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 41 most recent of 41 transactions on file: 2 with code P, 0 with code S and 39 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | HOMBACH ROBERT J. | Director | P Purchase | 13,000 | $18.14 | $235,768 |
| May 4, 2026 | ARCH Venture Partners XII, LLC | 10% Owner | P Purchase | 1,100,000 | $18.00 | $19,800,000 |
| May 4, 2026 | Loebel Antony | Chief Medical Officer | C Conversion | 20,109 | Not measured | Not measured |
| May 4, 2026 | PAUL STEVEN M | Director | C Conversion | 210,526 | Not measured | Not measured |
| May 4, 2026 | ARCH Venture Partners XII, LLC | 10% Owner | C Conversion | 2,513,686 | Not measured | Not measured |
| May 4, 2026 | ARCH Venture Partners XII, LLC | 10% Owner | C Conversion | 2,681,265 | Not measured | Not measured |
| May 4, 2026 | PureTech Health plc | 10% Owner | C Conversion | 12,736,014 | Not measured | Not measured |
| May 4, 2026 | HEALY JAMES | Director | C Conversion | 1,927,159 | Not measured | Not measured |
| May 4, 2026 | Loebel Antony | Chief Medical Officer | C Conversion | 63,157 | Not measured | Not measured |
| May 4, 2026 | PureTech Health plc | 10% Owner | C Conversion | 2,681,265 | Not measured | Not measured |
| May 4, 2026 | PureTech Health plc | 10% Owner | C Conversion | 40,000,000 | Not measured | Not measured |
| May 4, 2026 | PureTech Health plc | 10% Owner | C Conversion | 8,421,052 | Not measured | Not measured |
| May 4, 2026 | PureTech Health plc | 10% Owner | C Conversion | 3,031,578 | Not measured | Not measured |
| May 4, 2026 | PureTech Health plc | 10% Owner | C Conversion | 965,255 | Not measured | Not measured |
| May 4, 2026 | HEALY JAMES | Director | C Conversion | 804,379 | Not measured | Not measured |
| May 4, 2026 | White Lauren | Chief Financial Officer | C Conversion | 6,702 | Not measured | Not measured |
| May 4, 2026 | HEALY JAMES | Director | C Conversion | 6,052,631 | Not measured | Not measured |
| May 4, 2026 | HEALY JAMES | Director | C Conversion | 2,526,315 | Not measured | Not measured |
| May 4, 2026 | Gladstein Lana | General Counsel | C Conversion | 33,515 | Not measured | Not measured |
| May 4, 2026 | White Lauren | Chief Financial Officer | C Conversion | 21,052 | Not measured | Not measured |
| May 4, 2026 | Chen Michael Cunyuan | Chief Scientific Officer | C Conversion | 3,351 | Not measured | Not measured |
| May 4, 2026 | Torres Denice | Director | C Conversion | 13,406 | Not measured | Not measured |
| May 4, 2026 | PAUL STEVEN M | Director | C Conversion | 67,031 | Not measured | Not measured |
| May 4, 2026 | Gladstein Lana | General Counsel | C Conversion | 105,263 | Not measured | Not measured |
| May 4, 2026 | ARCH Venture Partners XII, LLC | 10% Owner | C Conversion | 2,513,686 | Not measured | Not measured |
| May 4, 2026 | Chen Michael Cunyuan | Chief Scientific Officer | C Conversion | 10,526 | Not measured | Not measured |
| May 4, 2026 | Torres Denice | Director | C Conversion | 42,105 | Not measured | Not measured |
| May 4, 2026 | ARCH Venture Partners XII, LLC | 10% Owner | C Conversion | 2,681,265 | Not measured | Not measured |
| Apr 30, 2026 | Loebel Antony | Chief Medical Officer | A Award | 63,680 | Not measured | Not measured |
| Apr 30, 2026 | Zohar Daphne | Chief Executive Officer | A Award | 271,813 | Not measured | Not measured |
| Apr 30, 2026 | Zohar Daphne | Chief Executive Officer | A Award | 1,486,786 | Not measured | Not measured |
| Apr 30, 2026 | White Lauren | Chief Financial Officer | A Award | 63,680 | Not measured | Not measured |
| Apr 30, 2026 | Wheadon David E. | Director | A Award | 12,258 | Not measured | Not measured |
| Apr 30, 2026 | PETERSON SANDRA E | Director | A Award | 12,258 | Not measured | Not measured |
| Apr 30, 2026 | Gladstein Lana | General Counsel | A Award | 63,680 | Not measured | Not measured |
| Apr 30, 2026 | Chen Michael Cunyuan | Chief Scientific Officer | A Award | 63,680 | Not measured | Not measured |
| Apr 30, 2026 | Torres Denice | Director | A Award | 12,258 | Not measured | Not measured |
| Apr 30, 2026 | PAUL STEVEN M | Director | A Award | 12,258 | Not measured | Not measured |
| Apr 30, 2026 | PAUL STEVEN M | Director | A Award | 991,192 | Not measured | Not measured |
| Apr 30, 2026 | HOMBACH ROBERT J. | Director | A Award | 12,258 | Not measured | Not measured |
| Apr 30, 2026 | Mates Sharon | Director | A Award | 49,033 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.